Capital Royalty, a Houston-based healthcare investor, has closed Capital Royalty Partners II with $805 million in equity commitments. The fund will work directly with healthcare companies, research institutions and investors and offer growth financing solutions for product commercialization, pipeline development and other opportunities. The firm will deploy the fund on a global basis and target investments between $20 million and $200 million.
